Arylamine N-acetyltransferases

Comprehensive Toxicology, Second Edition

Volumn 4, Issue , 2010, Pages 385-412

  Sim, E ^a   Fullam, E ^a   Wakefield, L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetyl CoA; Acetylation; Active site cysteine; Arylamines; Carcinogenesis; Catalytic triad; Isoniazid; Mycobacteria; NMR; P aminosalicylate; Pharmacogenetics; Polymorphisms; Protein structure; Systemic lupus erythematosus

Indexed keywords

EID: 85012841925     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-046884-6.00419-X     Document Type: Chapter

References (222)

1. Abu-Zeid M., Nagata K., Miyata M., Ozawa S., Fukuhara M., Yamazoe Y., Kato K.R. Mol. Carcinog. 1991, 4:81-88.
2. Adam P.J., Berry J., Loader J.A., Tyson K.L., Craggs G., Smith P., De Belin J., Steers G., Pezzerella F., Sachsenmeir K.F., et al. Mol. Cancer Res. 2003, 1:826-835.
3. Anderton M.C., Bhakta S., Besra G.S., Jeavons P., Eltis L.D., Sim E. Mol. Microbiol. 2006, 59:181-192.
4. Andres H.H., Klem A.J., Schopfer L.M., Harrison J.K., Weber W.W. J. Biol. Chem. 1988, 263:7521-7527.
5. Andres H.H., Kolb H.J., Schreiber R.J., Weiss L. Biochim. Biophys. Acta 1983, 746:193-201.
6. Andres H.H., Vogel R.S., Tarr G.E., Johnson L., Weber W.W. Mol. Pharmacol. 1987, 31:446-456.
7. Ashton L.J., Murray J.E., Haber M., Marshall G.M., Ashley D.M., Norris M.D. Pharmacogenet. Genomics 2007, 17:709-717.
8. Badawi A.F., Hirvonene A., Bell D.A., Lang N.P., Kadlubar F.F. Cancer Res. 1995, 55:5230-5237.
9. Barker D.F., Husain A., Neale J.R., Martini B.D., Zhang X., Doll M.A., States J.C., Hein D.W. Pharmacogenet. Genomics 2006, 16:515-525.
10. Bell D.A., Badawi A.F., Lang N.P., Ilett K.F., Kadlubar F.F., Hirvonen A. Cancer Res. 1995, 55:5226-5229.
11. Bell D.A., Taylor J.A., Butler M.A., Stephens E.A., Wiest J., Brubaker L.H., Kadlubar F.F., Lucier G.W. Carcinogenesis 1993, 14:1689-1692.
12. Bergstrom C.P., Wagner C.R., Ann D.K., Hanna P.E. Protein Expr. Purif. 1995, 6:45-55.
13. Bhakta S., Besra G.S., Upton A.M., Parish T., Sholto-Douglas-Vernon C., Gibson K.J.C., Knutton S., Gordon S., DaSilva R., Sim E. J. Exp. Med. 2004, 99:1191-1199.
14. Bièche I., Girault I., Urbain E., Tozlu S., Lidereau R. Breast Cancer Res. 2004, 6:252-263.
15. Blum M., Grant D.M., Demierre A., Meyer U.A. Proc. Natl. Acad. Sci. USA 1989, 86:9554-9557.
16. Blum M., Demierre A., Grant D.M., Heim M., Meyer U.A. Proc. Natl. Acad. Sci. USA 1991, 88:5237-5241.
17. Blum M., Grant D.M., McBride W., Heim M., Meyer U.A. DNA Cell Biol. 1990, 9:193-203.
18. Bonicke R., Reif W. Arch. Exp. Pathol. Pharmak. 1953, 220:321-323.
19. Boukouvala S., Fakis G. Drug Metab. Rev. 2005, 37:511-564.
20. Boukouvala S., Price N., Plant K.E., Sim E. Biochem. J. 2003, 375:593-602.
21. Boukouvala S., Price N., Sim E. Pharmacogenetics 2002, 12:385-394.
22. Boukouvala S., Sim E. Basic Clin. Pharmacol. Toxicol. 2005, 96:343-351.
23. Boukouvala S., Westwood I.M., Butcher N.J., Fakis G. Pharmacogenetics. 2008, 765-771.
24. Brooke E.W., Davies S.G., Mulvaney A.W., Okada M., Pompeo F., Sim E., Vickers R.J., Westwood I.M. Bioorg. Med. Chem. Lett. 2003, 13:2527-2530.
25. Brooke E.W., Davies S.G., Mulvaney A.W., Pompeo F., Sim E., Vickers R.J. Bioorg. Med. Chem. 2003, 11:1227-1234.
26. Bruhn C., Brockmoller J., Cascorbi I., Roots I., Borchert H.H. Biochem. Pharmacol. 1999, 58:1759-1764.
27. Butcher N.J., Arulpragasam A., Goh H.L., Davey T., Minchin R.F. Biochem. J. 2005, 387:119-127.
28. Butcher N.J., Arulpragasam A., Minchin R.F. J. Biol. Chem. 2004, 279:22131-22137.
29. Butcher N.J., Arulpragasam A., Pope C., Minchin R.F. Biochem. J. 2003, 376:441-448.
30. Butcher N.J., Ilett K.F., Minchin R.F. Pharmacogenetics 1998, 8:67-72.
31. Butcher N.J., Ilett K.F., Minchin R.F. Mol. Pharmacol. 2000, 57:468-473.
32. Butcher N.J., Tetlow N.L., Cheung C., Broadhurst G.M., Minchin R.F. Cancer Res. 2007, 6:785-792.
33. Cao W., Chau B., Hunter R., Strnatka D., McQueen C.A., Erickson R.P. Pharmacogenomics J. 2005, 5:255-261.
34. Carreon T., Ruder A.M., Schulte P.A., Hayes R.B., Rothman N., Waters M., Grant D.J., Boissy R., Bell D.A., Kadlubar F.F., et al. Int. J. Cancer 2006, 118:161-168.
35. Cartwright R.A., Glashan R.W., Rogers H.J., Ahmad R.A., Barham-Hall D., Higgins E., Kahn M.A. Lancet 1982, 16:842-845.
36. Chung J.G., Levy G.N., Weber W.W. Drug Metab. Dispos. 1993, 21:1057-1063.
37. Cornish V.A., Pinter K., Boukouvala S., Johnson N., Labrousse C., Payton M., Priddle H., Smith A.J., Sim E. Pharmacogenomics J. 2003, 3:169-177.
38. Coroneos E., Sim E. Biochem. J. 1993, 294:481-486.
39. Cribb A.E., Grant D.M., Miller M.A., Spielberg S.P. J. Pharmacol. Exp. Ther. 1991, 259:1241-1246.
40. Dairou J., Atmane N., Rodrigues-Lima F., Dupret J.M. J. Biol. Chem. 2004, 279:7708-7714.
41. Dairou J., Flatters D., Chaffotte A.F., Pluvinage B., Sim E., Dupret J.M., Rodrigues-Lima F. FEBS Lett. 2006, 580:1780-1788.
42. Dairou J., Malecaze F., Dupret J.M., Rodrigues-Lima F. Mol. Pharmacol. 2005, 67:1299-1306.
43. Deguchi T. J. Biol. Chem. 1992, 267:18140-18147.
44. Deguchi T., Mashimo M., Suzuki T. J. Biol. Chem. 1990, 265:12757-12760.
45. Deguchi T., Sakamoto Y., Sasaki Y., Uyemura K. J. Biol. Chem. 1988, 263:7528-7533.
46. Delgoda R., Lian L.Y., Sandy J., Sim E. Biochim. Biophys. Acta 2003, 1620:8-14.
47. Delomenie C., Fouix S., Longuemaux S., Brahimi N., Bizet C., Picard B., Denamur E., Dupret J.M. J. Bacteriol. 2001, 183:3417-3427.
48. Derewlany L.O., Knie B., Koren B. J. Pharm. Exp. Ther. 1994, 269:756-760.
49. Derewlany L.O., Knie B., Koren B. J. Pharm. Exp. Ther. 1994, 269:761-765.
50. Doll M.A., Hein D.W. Pharmacogenetics 1995, 5:247-251.
51. DuPret J.-M., Grant D.M. J. Biol. Chem. 1992, 267:7381-7385.
52. Dyda F., Klein D.C., Hickman A.B. Annu. Rev. Biophys. Biomol. Struct. 2000, 29:81-103.
53. Ebisawa T., Deguchi T. Biochem. Biophys. Res. Commun. 1991, 177:1252-1257.
54. Einisto P., Watanabe M., Ishidate M., Nohmi T. Mutat. Res. 1991, 259:95-102.
55. Estrada-Rodgers L., Levy G.N., Weber W.W. Drug Metab. Dispos. 1998, 26:502-505.
56. Estrada-Rodgers L., Levy G.N., Weber W.W. Gene Expr. 1998, 7:13-24.
57. Evans D.A., Manley K.A., McKuisick V.A. Br. Med. J. 1960, 2:485-491.
58. Evans D.A., White T.A. J. Lab. Clin. Med. 1964, 63:394-403.
59. Fakis G., Boukouvala S., Buckle V., Payton M., Denning C., Sim E. Cytogenet. Cell Genet. 2000, 90:134-138.
60. Fakis G., Boukouvala S., Kawamura A., Kennedy S. Pharmacogenet. Genomics 2007, 17:181-188.
61. Ferguson R.J., Doll M.A., Rustan T.D., Hein D.W. Pharmacogenetics 1996, 6:55-66.
62. Franke S., Klawitz I., Schnakenberg E., Rommel B., van den Ven W., Bullerdiek J., Schloot W. Biochem. Biophys. Res. Commun. 1994, 199:52-55.
63. Fretland A.J., Doll M.A., Gray K., Feng Y., Hein D. Toxicol. Appl. Pharmacol. 1997, 142:360-366.
64. Fullam, E. D. Phil. Thesis, University of Oxford, 2007.
65. Fullam E., Westwood I.M., Anderton M.C., Lowe E.D., Sim E., Noble M.E.M. J. Mol. Biol. 2008, 375:178-191.
66. Nature 2007, 449:851-861. GAIN collaborative research group.
67. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., Baranova H., Bathum L., Benhamou S., Boffetta P., et al. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1239-1248.
68. Glenn A.E., Meredith F.I., Morrison W.H., Bacon C.W. Appl. Environ. Microbiol. 2003, 69:3165-3169.
69. Glowinski I.B., Weber W.W. J. Biol. Chem. 1982, 257:1431-1437.
70. Goodfellow G.H., Dupret J.M., Grant D.M. Biochem. J. 2000, 348:159-166.
71. Grant D.M., Hughes N.C., Janezic S.A., Goodfellow G.H., Chen H.J., Gaedigk A., Yu V.L., Grewal R. Mutat. Res. 1997, 376:61-70.
72. Guo W.C., Lin G.F., Chen J.G., Golka K., Shen J.H. Arch. Toxicol. 2004, 78:425-429.
73. Guo Z., Wagner C.R., Hanna P.E. Chem. Res. Toxicol. 2004, 17:275-286.
74. Hayes R.B., Bi W., Rothman N., Broly F., Caporaso N., Feng P., You X., Yin S., Woosley R.L., Meyer U.A. Carcinogenesis 1993, 14:675-678.
75. Hein D.W. Mutat. Res. 2002, 506-507:65-77.
76. Hein D.W. Oncogene 2006, 25:1649-1658.
77. Hein D.W., Boukouvala S., Grant D.M., Minchin R.F., Sim E. Pharmacogenet. Genomics 2008, 18:367-368.
78. Hein D.W., Doll M.A., Fretland A.J., Leff M.A., Webb S.J., Xiao G.H., Devanaboyina U.S., Nangju N.A., Feng Y. Cancer Epidemiol. Biomarkers. Prev. 2000, 9:29-42.
79. Hein D.W., Doll M.A., Nerland D.E., Fretland A.J. Mol. Carcinogen. 2006, 45:230-238.
80. Hein D.W., Doll M.A., Rustan T.D., Gray K., Ferguson R.J., Feng Y. Toxicol. Appl. Pharmacol. 1994, 124:16-24.
81. Hickman D., Pope J., Patil S.D., Fakis G., Smelt V., Stanley L.A., Payton M., Unadkat J.D., Sim E. Gut 1998, 42:402-409.
82. Hickman D., Risch A., Buckle V., Spurr N.K., Jeremiah S.J., McCarthy A., Sim E. Biochem. J. 1994, 297:441-445.
83. Hickman D., Sim E. Biochem. Pharm. 1991, 42:1007-1014.
84. Holton S.J., Dairou J., Sandy J., Rodrigues-Lima F., Dupret J.M., Noble M.E., Sim E. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2005, 61:14-16.
85. Hubbard A.L., Harrison D.J., Moyes C., Wyllie A.H., Cunningham C., Mannion E., Smith C.A. Gut 1997, 41:229-234.
86. Hubbard A., Moyes C., Wyllie A.H., Smith C.A.D., Harrison D.J. Br. J. Cancer 1998, 77:913-916.
87. Hughes N.C., Janezic S.A., McQueen K.L., Jewett M.A., Castranio T., Bell D.A., Grant D.M. Pharmacogenetics 1998, 8:55-66.
88. Husain A., Barker D.F., States J.C., Doll M.A., Hein D.W. Pharmacogenetics 2004, 14:397-406.
89. Husain A., Zhang X., Doll M.A., States J.C., Barker D.F., Hein D.W. Drug Metab. Dispos. 2007, 35:1649-1656.
90. Husain A., Zhang X., Doll M.A., States J.C., Barker D.F., Hein D.W. Drug Metab. Dispos. 2007, 35:721-727.
91. Jencks W.P., Gresser M., Valenzuela M.S., Huneeus F.C. J. Biol. Chem. 1972, 247:3756-3760.
92. Jenne J.W. J. Clin. Invest. 1965, 44:1992-2002.
93. Jensen L.E., Hoess K., Mitchell L.E., Whitehead A.S. Hum. Genet. 2006, 120:52-57.
94. Jensen L.E., Hoess K., Whitehead A.S., Mitchell L.E. Birth Defects Res. 2005, 73:512-516.
95. Johnson, N. D. Phil. Thesis, University of Oxford, 2001.
96. Johnson N., Bell P., Jonovska V., Budge M., Sim E. BMC Med. Genet. 2004, 5:6.
97. Josephy P.D. Toxicology 2002, 181-182:255-260.
98. Kalow W. Clin. Pharmacokinet. 1982, 7:373-400.
99. Karolyi J., Erickson R.P., Liu S., Killewald L. Genetics 1990, 126:201-205.
100. Kawamura A., Graham J., Mushtaq A., Tsiftsoglou S.A., Vath G.M., Hanna P.E., Wagner C.R., Sim E. Biochem. Pharmacol. 2005, 69:347-349.
101. Kawamura A., Westwood I., Wakefield L., Long H., Zhang N., Walters K., Redfield C., Sim E. Biochem. Pharmacol. 2008, 75:1550-1560.
102. Kelly S.L., Sim E. Hum. Exp. Toxicol. 1991, 10:33-38.
103. Kelly S.L., Sim E. Biochem. J. 1994, 302:347-353.
104. Kim S.J., Kang H.S., Chang H.I., Jung Y.C., Sim H.B., Lee K.S., Ro J., Lee E.S. Oncol. Rep. 2008, 19:663-668.
105. Kloth M.T., Gee R.L., Messing E.M., Swaminathan S. Carcinogenesis 1994, 15:2781-2787.
106. Lammer E.J., Shaw G.M., Iovannisci D.M., Finnell R.H. Birth Defects Res. 2004, 70:846-852.
107. Lammer E.J., Shaw G.M., Iovannisci D.M., Van Waes J., Finnell R.H. Epidemiology 2004, 15:150-156.
108. Land S.J., Jones R.E., King C.M. Carcinogenesis 1994, 15:1585-1595.
109. Lau E.Y., Felton J.S., Lightstone F.C. Chem. Res. Toxicol. 2006, 19:1182-1190.
110. Lee J.H., Chung J.G., Lai J.M., Levy G.N., Weber W.W. Cancer Lett. 1997, 111:39-50.
111. Lin H.J., Han C.-Y., Lin B.K., Hardy S. Pharmacogenetics 1994, 4:125-134.
112. Lipmann F. Bacteriol. Rev. 1953, 17:1-16.
113. Lissowska J., Brinton L.A., Zatonski W., Bardin-Mokolajczak A., Peplonska B., Sherman M.E., Szeszenia-Dabrowska N., Chanock S., Chanock S., Garcia-Closas M. International J. Cancer 2006, 119:1961-1969.
114. Liu F., Zhang N., Zhou X., Hanna P.E., Wagner C.R., Koepp D.M., Walters K.J. J. Mol. Biol. 2006, 361:482-492.
115. Liu Y., Levy G.N. Cancer Lett. 1998, 133:115-123.
116. Loehle J.A., Cornish V., Wakefield L., Dol M.A., Neale J.R., Zang Y., Sim E., Hein D.W. J. Pharmacol. Exper. Ther. 2006, 319:724-728.
117. Lo-Guidice J.M., Allorge D., Chevalier D., Debuysere H., Fazio F., Lafitte L.J., Broly F. Pharmacogenetics 2000, 10:293-300.
118. Magalon H., Patin E., Austerlitz F., Hegay T., Aldashev A., Quintana-Murci L., Heyer E. J. Hum. Genet. 2008, 16:243-251.
119. Martell K.J., Levy G.N., Weber W.W. Mol. Pharmacol. 1992, 42:265-272.
120. Martell K.J., Vatsis K.P., Weber W.W. Mol. Pharmacol. 1991, 40:218-227.
121. Matas N., Thygesen P., Stacey M., Risch A., Sim E. Cytogenet. Cell. Genet. 1997, 77:290-295.
122. Mattano S.S., Erickson R.P., Nesbitt M.N., Weber W.W. J. Hered. 1988, 79:430-433.
123. McQueen C.A., Chau B. Toxicol. Sci. 2003, 73:279-286.
124. McQueen C.A., Mitchell M.K., Dang L.N., Chau B., Tjalkens R.B., Philbert M.A. Chem. Biol. Interact. 2003, 145:77-87.
125. McQueen C.A., Weber W.W. Biochem. Genet. 1980, 18:889-904.
126. Minchin R.F. Biochem. J. 1995, 307:1-3.
127. Minchin R.F., Hanna P.E., Dupret J.M., Wagner C.R., Rodrigues-Lima F., Butcher N.J. Int. J. Biochem. Cell Biol. 2007, 39:1999-2005.
128. Mitchell K.R., Warshawsky D. Toxicol. Lett. 2003, 139:11-23.
129. Mitchell M.K., Futscher B.W., McQueen C.A. Drug Metab. Dispos. 1999, 27:261-264.
130. Mitchell R.S., Bell J.C. Trans. Am. Clin. Climatol. Assoc. 1957, 69:98-102.
131. Mushtaq A., Payton M., Sim E. J. Biol. Chem. 2002, 277:12175-12181.
132. Nagata K., Ozawa S., Miyata M., Shimada M., Yamazoe Y., Kato R. Pharmacogenetics 1994, 4:91-100.
133. Nakura H., Itoh S., Kusano H., Ishizone H., Deguchi T., Kamataki T. Biochem. Pharmacol. 1995, 50:1165-1170.
134. Ochs-Balcom H.M., Wiesner G., Elston R.C. Am. J. Epidemiol. 2007, 166:246-254.
135. Ohsako S., Deguchi T. J. Biol. Chem. 1990, 265:4630-4634.
136. Ohsako S., Ohtomi M., Sakamoto Y., Uyemura K., Deguchi T. J. Biol. Chem. 1988, 263:7534-7538.
137. Pacifici G.M., Bencini C., Rane A. Pharmacology 1986, 32:283-291.
138. Patin E., Barreiro L.B., Sabeti P.C., Austerlitz A., Luca F., Sajantila A., Behar D.M., Semino O., Sakuntabhai A., Guiso N., et al. Am. J. Hum. Genet. 2006, 78:423-436.
139. Payton M., Auty R., Delgoda R., Everett M., Sim E. J. Bacteriol. 1999, 181:1343-1347.
140. Payton M., Gifford C., Schartau P., Hagemeier C., Mushtaq A., Lucas S., Pinter K., Sim E. Microbiology 2001, 147:3295-3302.
141. Payton M., Mushtaq A., Yu T., Wu L., Sinclair J., Sim E. Microbiology 2001, 147:1137-1147.
142. Payton M.A., Sim E. Biochem. Pharm. 1998, 55:361-366.
143. Payton M., Smelt V., Upton A., Sim E. Biochem. Pharmacol. 1999, 58:779-785.
144. Pluvinage B., Dairou J., Possot O.M., Martins M., Fouet A., Dupret J.M., Rodrigues de Lima F. Biochemistry 2007, 46:7069-7078.
145. Pompeo F., Brooke E.W., Kawamura A., Mushtaq A., Sim E. Pharmacogenomics 2002, 3:19-30.
146. Pompeo F., Mushtaq A., Sim E. Protein Expr. Purif. 2002, 24:138-151.
147. Riddle B., Jencks W.P. J. Biol. Chem. 1971, 246:3250-3258.
148. Risch A., Wallace D.M.A., Bathers S., Sim E. Hum. Mol. Genet. 1995, 4:231-236.
149. Rodrigues-Lima F., Dairou J., Diaz C.L., Rubio M.C., Sim E., Spaink H.P., Dupret J.M. Mol. Microbiol. 2006, 60:505-512.
150. Rubin R.L. Toxicology 2005, 209:135-147.
151. Sadrieh N., Davis C.D., Snyderwine E.G. Cancer Res. 1996, 56:2683-2687.
152. Sandy J., Mushtaq A., Holton S.J., Schartau P., Noble M.E.M., Sim E. Biochem. J. 2005, 390:115-123.
153. Sandy J., Mushtaq A., Kawamura A., Sinclair J., Sim E., Noble M. J. Mol. Biol. 2002, 318:1071-1083.
154. Sasaki Y., Ohsako S., Deguchi T. J. Biol. Chem. 1991, 266:13243-13250.
155. Sholto-Douglas-Vernon C., Sandy J., Victor T.C., Sim E., van Helden P.D. J. Med. Microbiol. 2005, 54:1189-1197.
156. Sim E., Boukouvala S., Walters K.A. Drug Metab. Rev. 2008, 40:479-510.
157. Sim E., Gill E.W., Sim R.B. Lancet 1984, 2:422-424.
158. Sim E., Hickman D. Trends Pharmacol. Sci. 1991, 12:211-213.
159. Sim E., Lack N., Wang C.-J., Wakefield L., Westwood I., Fullam E., Kawamura A. Toxicology 2008, 254:170-183.
160. Sim E., Pinter K., Mushtaq A., Upton A., Sandy J., Bhakta S., Noble M. Biochem. Soc. Trans. 2003, 31:615-619.
161. Sim E., Stanley L.A., Risch A., Thygesen P. Trends Genet. 1995, 11:509-512.
162. Sim E., Westwood I., Fullam E. Expert Opin. Drug. Metab. Toxicol. 2007, 3:169-184.
163. Sinclair, J. C.D. Phil. Thesis, University of Oxford, 1999.
164. Sinclair J.C., Delgoda R., Noble M.E., Jarmin S., Goh N., Sim E. Protein. Expr. Purif. 1998, 12:371-380.
165. Sinclair J.C., Sandy J., Delgoda R., Sim E., Noble M.E. Nat. Struct. Biol. 2000, 7:560-564.
166. Sinclair J.C., Sim E. Biochem. Pharmacol. 1997, 53:11-16.
167. Smelt V.A., Mardon H.J., Sim E. Pharmacol. Toxicol. 1998, 83:149-157.
168. Smelt V.A., Upton A., Adjaye J., Payton M.A., Boukouvala S., Johnson N., Mardon H.J., Sim E. Hum. Mol. Genet. 2000, 9:1101-1107.
169. Smolen T.N., Brewer J.A., Weber W.W. J. Pharmacol. Exp. Ther. 1993, 264:854-858.
170. Stacey M., Matas N., Drake M., Payton M., Fakis G., Greenland J., Sim E. Genes Chromosomes Cancer 1999, 25:376-383.
171. Stanley L.A., Copp A.J., Pope J., Rolls S., Smelt V., Perry V.H., Sim E. Teratology 1998, 58:174-182.
172. Stanley L.A., Coroneos E., Cuff R., Hickman D., Ward A., Sim E. J. Histochem. Cytochem. 1996, 44:1059-1067.
173. Stanley L.A., Mills I.G., Sim E. Pharmacogenetics 1997, 7:121-130.
174. Sticha K.R.K., Sieg C.A., Bergstrom C.P., Hanna P.E., Wagner C.R. Protein Expr. Purif. 1997, 10:141-153.
175. Strandberg I., Boman G., Hassler L., Sjoquist F. Acta Med. Scand. 1976, 200:367-371.
176. Sugamori K.S., Brenneman D., Grant D.M. Drug Metab. Dispos. 2006, 34:1697-1702.
177. Sugamori K.S., Brenneman D., Wong S., Gaedigk A., Yu V., Abramovici H., Rozmahel R., Grant D.M. Drug Metab. Dispos. 2007, 35:1064-1070.
178. Sugamori K.S., Wong S., Gaedigk A., Yu V., Abramovici H., Rozmahel R., Grant D.M. Mol. Pharmacol. 2003, 64:170-179.
179. Suzuki H., Ohnishi Y., Horinouchi S. J. Bacteriol. 2007, 189:2155-2159.
180. Taioli E. Cancer Epidemiol. Biomarkers Prev. 1999, 8:727-728.
181. Trepanier L.A., Cribb A., Spielberg S.P., Ray K. Pharmacogenetics 1998, 8:169-179.
182. Trepanier L.A., Ray K., Winand N.J., Spielberg S.P., Cribb A.E. Biochem. Pharmacol. 1997, 54:73-80.
183. Trinidad A., Hein D.W., Rustan T.D., Ferguson R.J., Miller L.S., Bucher K.D., Kirlin W.G., Ogolla F., Andrews A.F. Cancer Res. 1990, 50:7942-7949.
184. Upton A., Everett M., Mushtaq A., van Helden P., Victor T., Wagner R., Sim E. Mol. Microbiol. 2001, 42:309-319.
185. Upton A., Johnson N., Sandy J., Sim E. Trends Pharmacol. Sci. 2001, 22:140-146.
186. van der Geize R., Heuser T., Yam K., Wilbrink M.H., Hara H., Anderton M.C., Sim E., Dijkuizen L., Davies J.E., Mohn W.W., et al. Proc. Natl. Acad. Sci. USA 2007, 104:1947-1952.
187. Vatsis K.P., Weber W.W. Arch Biochem. Biophys. 1993, 301:71-76.
188. Vatsis K., Weber W. Comprehensive Toxicology 1997, 385-400. Elsevier Science Inc., New York. I.G. Sipes, A.J. Gandolfi, C.A. McQueen (Eds.).
189. Vineis P., Marinelli D., Autrup H., Brockmoller J., Cascorbi I., Daly A.K., Golka K., Okkels H., Risch A., Rothman N., et al. Cancer Epidemiol. Biomarkers Prev. 2001, 10:1249-1252.
190. Wakefield L., Cornish V., Broackes-Carter F., Sim E. J. Histochem. Cytochem. 2005, 53:583-592.
191. Wakefield L., Cornish V., Long H., Griffiths W.J., Sim E. Biochem. Biophys. Res. Commun. 2007, 364:556-560.
192. Wakefield L., Cornish V., Long H., Kawamura A., Zhang X., Hein D.W., Sim E. Biomarkers 2008, 13:106-118.
193. Wakefield L., Long H., Lack N., Sim E. Mamm. Genome 2007, 18:270-276.
194. Wakefield L., Robinson J., Long H., Ibbit J.C., Cooke S., Hurst H.C., Sim E. Genes Chromosomes Cancer 2008, 47:118-126.
195. Walraven J.M., Barker D.F., Doll M.A., Hein D.W. Toxicol. Sci. 2007, 99:413-421.
196. Walraven J.M., Doll M.A., Hein D.W. J. Pharmacol. Exp. Ther. 2006, 319:369-375.
197. Walraven J.M., Trent J.O., Hein D.W. Drug Metab. Dispos. 2007, 35:1001-1007.
198. Wang H., Liu L., Hanna P.E., Wagner C.R. Biochemistry 2005, 44:11295-11306.
199. Wang H., Vath G.M., Gleason K.J., Hanna P.E., Wagner C.R. Biochemistry 2004, 43:8234-8246.
200. Wang H., Wagner C.R., Hanna P.E. Chem. Res. Toxicol. 2005, 18:183-197.
201. Wang L., Nguyen T.V., McLaughlin R.W., Sikkink L.A., Ramirez-Alvarado M., Weinshilboum R.M. Proc. Natl. Acad. Sci. USA 2005, 102:9394-9399.
202. Ward A., Summers M.J., Sim E. Biochem. Pharmacol. 1995, 49:1759-1767.
203. Warren R.M., Gey van Pittius N.C., Barnard M., Hesseling A., Engelke E., de Kock M., Gutierrez M.C., Chege G.K., Victor T.C., Hoal E.G., et al. Int. J. Tuberc. Lung Dis. 2006, 10:818-822.
204. Watanabe M., Sofuni T., Nohmi T. J. Biol. Chem. 1992, 267:8429-8436.
205. Watson A.P., Wang P.D., Sim E. Biochem. Pharmacol. 1990, 39:647-654.
206. Weber W.W. Mol. Diagn. 1999, 4:299-307.
207. Weber W.W., Hein D.W. Pharmacol. Rev. 1985, 37:25-79.
208. Westwood I.M., Holton S.J., Rodrigues-Lima F., Dupret J.M., Bhakta S., Noble M.E., Sim E. Biochem. J. 2005, 385:605-612.
209. Westwood I.M., Kawamura A., Fullam E., Russell A.J., Davies S.G., Sim E. Curr. Top. Med. Chem. 2006, 6:1641-1654.
210. Westwood I.M., Sim E. BMC Biotechnol. 2007, 8:1-14. doi:110.1186/1471-2091-8-3.
211. Williams J.A., Stone A.M., Fakis G., Johnson N., Cordell J.A., Meinl W., Glatt H., Sim E., Phillips D.H. Pharmacogenetics 2001, 11:373-388.
212. Windmill K.F., Gaedigk A., Hall P.M., Samaratunga H., Grant D.M., McManus M. Toxicol. Sci. 2000, 54:19-29.
213. Wlaschin K.F., Hu W.-S. Biotechnol. Bioeng. 2007, 98:429-439.
214. Woosley R.L. Annu. Rev. Pharmacol. Toxicol. 1991, 31:427-455.
215. Wu H., Dombrovsky L., Tempel W., Martin F., Loppnau P., Goodfellow G.H., Grant D.M., Plotnikov A.N. J. Biol. Chem. 2007, 282:30189-30197.
216. Yamamoto M., Sobue G., Mukoyama M., Matsuoka Y., Mitsuma T. J. Neurol. Sci. 1996, 135:51-54.
217. Yu T.W., Shen Y., Doi-Katayama Y., Tang L., Park C., Moore B.S., Richard Hutchinson C., Floss H.G. Proc. Natl. Acad. Sci. USA 1999, 96:9051-9056.
218. Yuliwulandari R., Sachrowardi Q., Nishida N., Takasu M., Batubara L., Susmiarsih T.P., Rochani J.T., Wikaningrum R., Miyashita R., Miyagawa T., et al. J. Hum. Genet. 2008, 53:201-209.
219. Zang Y., Zhao S., Doll M.A., States J.C., Hein D.W. Pharmacogenetics 2004, 14:717-723.
220. Zang Y., Zhao S., Doll M.A., States J.C., Hein D.W. Pharmacogen. Genomics 2007, 17:37-45.
221. Zhang N., Liu L., Liu F., Wagner C.R., Hanna P.E., Walters K.J. J. Mol. Biol. 2006, 363:188-200.
222. Zhu Y., Hein D.W., Doll M.A., Reynolds K.K., Abudu N., Valdes R., Linder M.W. Clin. Chem. 2006, 526:1033-1039.